| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7144 | 2015 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … M Correction Naghavi, H Wang, R Lozano, A Davis, X Liang, M Zhou, ... The Lancet 385 (9963), 117-171, 2015 | 4754 | 2015 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 2478* | 2015 |
| Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis R Lozano, H Wang, KJ Foreman, JK Rajaratnam, M Naghavi, JR Marcus, ... The lancet 378 (9797), 1139-1165, 2011 | 1228 | 2011 |
| Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010 H Wang, L Dwyer-Lindgren, KT Lofgren, JK Rajaratnam, JR Marcus, ... The Lancet 380 (9859), 2071-2094, 2012 | 1141 | 2012 |
| Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 H Wang, CA Liddell, MM Coates, MD Mooney, CE Levitz, AE Schumacher, ... The Lancet 384 (9947), 957-979, 2014 | 1051 | 2014 |
| Advancing digital health applications: priorities for innovation in real-world evidence generation AD Stern, J Brönneke, JF Debatin, J Hagen, H Matthies, S Patel, I Clay, ... The Lancet Digital Health 4 (3), e200-e206, 2022 | 99 | 2022 |
| GBD 2010 country results: a global public good C Murray, V Aboyans, J Abraham, H Ackerman, S Ahn, M Ali, M Almazroa, ... Deakin University, 2013 | 35 | 2013 |
| The cost-effectiveness of preimplantation genetic testing for aneuploidy in the United States: an analysis of cost and birth outcomes from 158,665 in vitro fertilization cycles M Lee, KT Lofgren, A Thomas, A Lanes, R Goldman, ES Ginsburg, ... American Journal of Obstetrics and Gynecology 225 (1), 55. e1-55. e17, 2021 | 33 | 2021 |
| Trends in use of next-generation sequencing in patients with solid tumors by race and ethnicity after implementation of the Medicare national coverage determination DM Sheinson, WB Wong, CS Meyer, S Stergiopoulos, KT Lofgren, ... JAMA Network Open 4 (12), e2138219-e2138219, 2021 | 26 | 2021 |
| Complementary roles for tissue-and blood-based comprehensive genomic profiling for detection of actionable driver alterations in advanced NSCLC LS Schwartzberg, G Li, K Tolba, AB Bourla, K Schulze, R Gadgil, A Fine, ... JTO Clinical and Research Reports 3 (9), 100386, 2022 | 23 | 2022 |
| Quantifying the value of multigene testing in resected early stage lung adenocarcinoma B Muthusamy, K Raskina, KT Lofgren, G Li, K Tolba, K Schwed, ... Journal of Thoracic Oncology 18 (4), 476-486, 2023 | 10 | 2023 |
| Precommitment, cash transfers, and timely arrival for birth: evidence from a randomized controlled trial in Nairobi Kenya J Cohen, K Lofgren, M McConnell American Economic Review 107 (5), 501-505, 2017 | 8 | 2017 |
| A novel HRD signature is predictive of FOLFIRINOX benefit in metastatic pancreatic cancer KT Chen, R Madison, J Moore, D Jin, Z Fleischmann, J Newberg, ... The Oncologist 28 (8), 691-698, 2023 | 6 | 2023 |
| Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non–Small-Cell Lung Cancer J Yorio, KT Lofgren, JK Lee, K Tolba, GR Oxnard, AB Schrock, ... JCO Precision Oncology 8, e2300292, 2024 | 2 | 2024 |
| Balancing health and financial protection in health benefit package design KT Lofgren, DA Watkins, ST Memirie, JA Salomon, S Verguet Health Economics 30 (12), 3236-3247, 2021 | 2 | 2021 |
| How can city planners improve health and reduce mortality in Alameda County, California? A cross-sectional analysis M Alvarado, KT Lofgren The Lancet 381, S7, 2013 | 2 | 2013 |
| Racial and ethnic inequities at the practice and physician levels in timely next-generation sequencing for patients with advanced non–small-cell lung cancer treated in the US … GA Vidal, N Jain, A Fisher, D Sheinson, KT Lofgren, E Ma, E Yu, ... JCO Oncology Practice 20 (3), 370-377, 2024 | 1 | 2024 |
| Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC PC Mack, RB Keller-Evans, G Li, KT Lofgren, AB Schrock, SE Trabucco, ... The Oncologist, oyae028, 2024 | 1 | 2024 |
| Practice-and provider-level inequities in next-generation sequencing (NGS) testing by race/ethnicity for patients (pts) with advanced non-small cell lung cancer (aNSCLC … GA Vidal, N Jain, A Fisher, D Sheinson, KT Lofgren, E Ma, E Yu, ... Journal of Clinical Oncology 41 (16_suppl), 6508-6508, 2023 | 1 | 2023 |
